Search results for "Highlights"


 
Results 1 - 10 of about 231 for "Highlights".
Sort by: Relevance | Newest | Oldest

In the Clinic, 2023 summary highlight gastroenterology topics

Colorectal cancer screening was the focus of the latest In the Clinic article, while an article in a supplement to Annals reviewed clinically important developments in gastroenterology and hepatology in 2023.
https://gastroenterology.acponline.org/archives/2024/04/26/5.htm
26 Apr 2024

Subscribe

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.
https://gastroenterology.acponline.org/subscribe/index.html

Higher MAP linked with AKI reversal among hospitalized patients

A 5 mm Hg increase in mean arterial pressure (MAP) was linked with a small but significant increase in the likelihood of reversal of acute kidney injury (AKI), according to a retrospective study of patients hospitalized with decompensated cirrhosis.
https://gastroenterology.acponline.org/archives/2024/04/26/2.htm
26 Apr 2024

GLP-1 receptor agonists could modestly delay gastric emptying during periprocedural fasting, study suggests

A systematic review and meta-analysis found that glucagon-like peptide-1 (GLP-1) receptor agonists were associated with a delay of approximately 36 minutes in gastric emptying on scintigraphy compared to placebo.
https://gastroenterology.acponline.org/archives/2024/04/26/3.htm
26 Apr 2024

Colectomy linked with greater risk of AKI, kidney failure in patients with IBD

Among patients with inflammatory bowel disease (IBD), colectomy was linked with more than doubled risk of acute kidney injury (AKI), indicating that these patients may benefit from close monitoring of kidney biomarkers, according to the authors of a Swedish cohort study.
https://gastroenterology.acponline.org/archives/2024/05/24/3.htm
24 May 2024

GLP-1s associated with lower risk of hepatic decompensation than other diabetes drugs

Patients taking glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes had lower risk of hepatocellular carcinoma than those on insulin or sulfonylureas, and hepatic decompensation risk was reduced compared with five comparison diabetes drug classes, a study found.
https://gastroenterology.acponline.org/archives/2024/05/24/2.htm
24 May 2024

Tranexamic acid may help with upper GI bleeding after esophageal variceal ligation

Tranexamic acid significantly reduced upper GI bleeding after esophageal variceal ligation, but mortality rates were similar to those with placebo, a trial in India found.
https://gastroenterology.acponline.org/archives/2024/03/22/3.htm
22 Mar 2024

Review finds antibiotics associated with heightened risk of inflammatory bowel disease

There was a positive, nonlinear dose-response association between the number of antibiotic prescriptions patients received and their inflammatory bowel disease risk, according to a systematic review.
https://gastroenterology.acponline.org/archives/2024/03/22/2.htm
22 Mar 2024

Restricting PPI prescription refills reduced use without noticeable clinical effects

Restrictions on proton-pump inhibitor (PPI) refills for patients without a documented long-term indication were associated with a rapid and sustained 7.3% absolute reduction in such prescriptions—a relative decline of nearly 30%, a Veterans Affairs study found.
https://gastroenterology.acponline.org/archives/2024/04/26/1.htm
26 Apr 2024

IV iron appears safe, effective for bleeding-related iron-deficiency anemia in cirrhosis

Patients with cirrhosis who had iron-deficiency anemia after variceal bleeding had greater improvement in clinical outcomes at three months with IV iron versus oral iron therapy, a randomized trial in India found.
https://gastroenterology.acponline.org/archives/2024/05/24/1.htm
24 May 2024

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next